Resources Library by ANA

Competitive intelligence

This paper has indicated that Competitive Intelligence represents the flip-side of the strategy coin. Strategy without intelligence, we have suggested, is not strategy, it is guessing. Some pharmaceutical firms are making considerable progress toward...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Douglas C. Bernhardt

June 1, 1995

Consumers’ attitude towards instructions

This paper will mainly show the actual interest patients feel towards the instructions but also the difficulties they face in trying to understand them accurately and will suggest ways to eliminate these problems. At the suggestion of the Austrian...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Lisl Putschi

Company: GfK

June 1, 1995

Forecasting pharmaceutical brands

The aim of this paper is to examine how pharmaceutical forecasting is currently conducted, from different clients' perspectives, to stimulate discussion and to make recommendations about how the practice could be improved. Pharmaceutical forecasting,...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Oliver Mast, Sandra Buckeldee

June 1, 1995

Good quality for better quantity

Structured and systematic monitoring of the competition is increasingly becoming a key means of assuring a company's success. While the collection and processing of relevant data is still relatively easy, analysis and interpretation of relevant...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Holger Paulsen

June 1, 1995

The 'heavyweights'

I plan to share with you some innovative market research completed to help us estimate the dollar potential for a prescription "weight loss" product in Europe using only medical promotional efforts. Our hypothesis was that even though we did not...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: William V. Lawson

June 1, 1995

Evaluating and forecasting prescribing

The paper is divided into four main sections. The Methodology describes the data upon which the analyses were based and explains the theoretical background to the approach adopted. The Results are then presented to show how large and small drugs...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Andrew S. C. Ehrenberg, Philip Stern

June 1, 1995

Through the looking glass

The paper describes a case study carried out in 1994 to examine the potential for a number of new possible line extensions (formulations) of an existing product. Management required an extremely accurate forecast of the likely impact of the new forms...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Raf De Wilde, Alan J. Bowditch, Simon Fitall

June 1, 1995

Developing integrated forecasts in an increasingly complex, global pharmaceutical market

As decision-making for prescription pharmaceuticals becomes increasingly pluralistic, forecasting the market share of a new product or line extension is more difficult than ever, especially in global, international applications. This paper presents a...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: William F. Mckenna, Girish Patwardhan, Juliet J. Goodfriend

June 1, 1995

ICC/ESOMAR international code of marketing and social research practice (French)

This Code sets out the basic principles which must guide the actions of those who carry outor use marketing research. Individuals and organizations that subscribe to it must follow notjust the letter but also the spirit of these rules.

Catalogue: ESOMAR Codes And Guidelines

Authors: ESOMAR B.V., ICC B.V.

May 3, 1995